• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状病毒病中的室性心动过速或心室颤动风暴

Ventricular Tachycardia or Fibrillation Storm in Coronavirus Disease.

作者信息

Khan Muhammad H, Aqtash Obadah, Harris David M, Costea Alexandru I, Gerson Myron C

机构信息

Department of Internal Medicine, University of Cincinnati, USA.

Department of Cardiovascular Medicine, University of Cincinnati, USA.

出版信息

Case Rep Cardiol. 2022 Aug 18;2022:1157728. doi: 10.1155/2022/1157728. eCollection 2022.

DOI:10.1155/2022/1157728
PMID:36032053
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9410984/
Abstract

Ventricular tachycardia (VT) or ventricular fibrillation (VF) storm associated with severe acute respiratory syndrome coronavirus 2 infection is a potentially fatal complication; the correlation of these 2 disorders, however, has not been well studied. This retrospective case series examined outcomes of 2 patients who were admitted for repeated implantable cardioverter-defibrillator shocks with or without syncope and observed to have VT/VF storms with COVID-19. Mechanisms of VT/VF storms in COVID-19 are multifactorial including myocarditis, systemic inflammation, hyperadrenergic state, hemodynamic instability, hypoxia, acidosis, and proarrhythmic drugs. A higher incidence of VT/VF storm is observed in patients with comorbidities and those requiring critical care, with some studies reporting increased mortality. In our cohort, 1 of the 2 patients succumbed to the complications from COVID-19, and the other patient was discharged to home in stable condition. Monitoring of life-threatening arrhythmias in the setting of COVID-19 may need to be adopted to prevent morbidity and mortality.

摘要

与严重急性呼吸综合征冠状病毒2感染相关的室性心动过速(VT)或室颤(VF)风暴是一种潜在的致命并发症;然而,这两种病症之间的相关性尚未得到充分研究。本回顾性病例系列研究了2例因反复接受植入式心律转复除颤器电击(伴或不伴晕厥)入院且被观察到患有COVID-19相关VT/VF风暴的患者的结局。COVID-19中VT/VF风暴的机制是多因素的,包括心肌炎、全身炎症、高肾上腺素能状态、血流动力学不稳定、缺氧、酸中毒和促心律失常药物。在合并症患者和需要重症监护的患者中观察到VT/VF风暴的发生率更高,一些研究报告死亡率增加。在我们的队列中,2例患者中有1例死于COVID-19并发症,另1例患者病情稳定后出院回家。在COVID-19背景下,可能需要对危及生命的心律失常进行监测,以预防发病和死亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c15f/9410984/8b9c37307609/CRIC2022-1157728.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c15f/9410984/f7a3577da6ab/CRIC2022-1157728.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c15f/9410984/80fdec04814c/CRIC2022-1157728.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c15f/9410984/90144fc3b3bf/CRIC2022-1157728.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c15f/9410984/077acc838307/CRIC2022-1157728.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c15f/9410984/8b9c37307609/CRIC2022-1157728.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c15f/9410984/f7a3577da6ab/CRIC2022-1157728.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c15f/9410984/80fdec04814c/CRIC2022-1157728.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c15f/9410984/90144fc3b3bf/CRIC2022-1157728.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c15f/9410984/077acc838307/CRIC2022-1157728.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c15f/9410984/8b9c37307609/CRIC2022-1157728.005.jpg

相似文献

1
Ventricular Tachycardia or Fibrillation Storm in Coronavirus Disease.冠状病毒病中的室性心动过速或心室颤动风暴
Case Rep Cardiol. 2022 Aug 18;2022:1157728. doi: 10.1155/2022/1157728. eCollection 2022.
2
Ventricular Tachycardia Storm in a Patient with an Implanted Cardioverter-Defibrillator Following COVID-19 Infection.一名植入式心脏复律除颤器患者在感染新型冠状病毒肺炎后发生室性心动过速风暴
J Tehran Heart Cent. 2022 Jan;17(1):22-25. doi: 10.18502/jthc.v17i1.9321.
3
Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy.植入式除颤器用于一级预防的心肌梗死后患者的室性心律失常风暴:MADIT-II 亚研究
Heart Rhythm. 2007 Nov;4(11):1395-402. doi: 10.1016/j.hrthm.2007.07.013. Epub 2007 Jul 17.
4
Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.儿茶酚胺能多形性室性心动过速的除颤治疗结果
Heart Rhythm. 2014 Jan;11(1):58-66. doi: 10.1016/j.hrthm.2013.10.027. Epub 2013 Oct 11.
5
Outcomes of rescue cardiopulmonary support for periprocedural acute hemodynamic decompensation in patients undergoing catheter ablation of electrical storm.经导管消融电风暴患者围术期急性血液动力学失代偿时抢救性心肺支持的结果。
Heart Rhythm. 2018 Jan;15(1):75-80. doi: 10.1016/j.hrthm.2017.09.005. Epub 2017 Sep 14.
6
Potential proarrhythmic effect of biventricular pacing: fact or myth?双心室起搏的潜在促心律失常作用:事实还是虚构?
Heart Rhythm. 2005 Sep;2(9):951-6. doi: 10.1016/j.hrthm.2005.05.019.
7
Implantable transvenous cardioverter-defibrillators.植入式经静脉心脏复律除颤器
Circulation. 1993 Apr;87(4):1152-68. doi: 10.1161/01.cir.87.4.1152.
8
[Long-term outcome after cardioverter-defibrillator implantation in patients with Brugada syndrome].[布加综合征患者植入心脏复律除颤器后的长期预后]
Zhonghua Xin Xue Guan Bing Za Zhi. 2015 Aug;43(8):690-4.
9
Implantable defibrillator event rates in patients with idiopathic dilated cardiomyopathy, nonsustained ventricular tachycardia on Holter and a left ventricular ejection fraction below 30%.特发性扩张型心肌病、动态心电图显示非持续性室性心动过速且左心室射血分数低于30%的患者植入式除颤器事件发生率。
J Am Coll Cardiol. 2002 Mar 6;39(5):780-7. doi: 10.1016/s0735-1097(01)01822-8.
10
Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.植入式心脏复律除颤器检测与治疗参数的策略性编程可减少一级预防患者的电击次数:PREPARE(一级预防参数评估)研究结果
J Am Coll Cardiol. 2008 Aug 12;52(7):541-50. doi: 10.1016/j.jacc.2008.05.011.

引用本文的文献

1
A Comprehensive Review of a Mechanism-Based Ventricular Electrical Storm Management.基于机制的心室电风暴管理综合综述
J Clin Med. 2025 Jul 29;14(15):5351. doi: 10.3390/jcm14155351.
2
Rhythm Disturbances in Post-Acute COVID-19 Syndrome in Young Men without Pre-Existing Known Cardiovascular Disease-A Case Series.无已知心血管疾病史的年轻男性急性 COVID-19 综合征后的节律紊乱——病例系列
Biomedicines. 2023 Apr 11;11(4):1146. doi: 10.3390/biomedicines11041146.
3
Long COVID-19 Myocarditis and Various Heart Failure Presentations: A Case Series.

本文引用的文献

1
Remdesivir-Induced Bradycardia in COVID-19: A Single Center Prospective Study.瑞德西韦致新型冠状病毒肺炎患者心动过缓:一项单中心前瞻性研究
Circ Arrhythm Electrophysiol. 2021 Jul;14(7):e009811. doi: 10.1161/CIRCEP.121.009811. Epub 2021 Jun 29.
2
SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction.SARS-CoV-2 定植于冠状动脉血栓中,并损害无症状 SARS-CoV-2 阳性急性心肌梗死患者的心脏微循环床。
Crit Care. 2021 Jun 24;25(1):217. doi: 10.1186/s13054-021-03643-0.
3
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte.
新冠后心肌炎及各种心力衰竭表现:病例系列
J Cardiovasc Dev Dis. 2022 Nov 30;9(12):427. doi: 10.3390/jcdd9120427.
糖尿病中糖化 ACE2 受体:SARS-COV-2 进入心肌细胞的门户。
Cardiovasc Diabetol. 2021 May 7;20(1):99. doi: 10.1186/s12933-021-01286-7.
4
Worldwide Survey of COVID-19-Associated Arrhythmias.COVID-19 相关心律失常的全球调查。
Circ Arrhythm Electrophysiol. 2021 Mar;14(3):e009458. doi: 10.1161/CIRCEP.120.009458. Epub 2021 Feb 7.
5
Incidence, risk factors, and thrombotic load of pulmonary embolism in patients hospitalized for COVID-19 infection.因 COVID-19 感染住院患者的肺栓塞发生率、风险因素和血栓负荷。
J Infect. 2021 Feb;82(2):261-269. doi: 10.1016/j.jinf.2021.01.003. Epub 2021 Jan 10.
6
Electrocardiographic manifestations of COVID-19.新型冠状病毒肺炎的心电图表现。
Am J Emerg Med. 2021 Mar;41:96-103. doi: 10.1016/j.ajem.2020.12.060. Epub 2020 Dec 29.
7
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.用于治疗新冠肺炎的抗病毒药物 repurposed - 世界卫生组织团结试验中期结果
N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2.
8
COVID-19: Electrophysiological mechanisms underlying sudden cardiac death during exercise with facemasks.COVID-19:戴口罩运动时导致心搏骤停的电生理学机制。
Med Hypotheses. 2020 Nov;144:110177. doi: 10.1016/j.mehy.2020.110177. Epub 2020 Aug 11.
9
Electrical storm in a patient with COVID-19 treated with hydroxychloroquine: A case report.一名接受羟氯喹治疗的新冠肺炎患者发生电风暴:病例报告
SAGE Open Med Case Rep. 2020 Nov 16;8:2050313X20974217. doi: 10.1177/2050313X20974217. eCollection 2020.
10
Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients.洛匹那韦-利托那韦、阿奇霉素和羟氯喹三联疗法对住院COVID-19患者QT间期及心律失常风险的影响
Front Pharmacol. 2020 Oct 8;11:582348. doi: 10.3389/fphar.2020.582348. eCollection 2020.